Companies International Flavors & Fragrances Inc
International Flavors & Fragrances (IFF): executive pay, fiscal 2025
Free brief. Every figure links to the company’s own filing.
Velarion Intel: free for 3 days, no card →Email me International Flavors & Fragrances Inc’s executive pay brief as a PDF
You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO vs. named peers50th pct.Of 20 peer CEOs
CEO pay, last three years
- $24,154,267FY2024
- $15,002,866FY2025
CEO total pay was $15,002,866 in fiscal 2025, down from $24,154,267 in fiscal 2024.
FY2025: salary $1,026,250 · stock awards $11,656,764 · option awards $0
Executives and directors
Andres Muller · PresidentJ. Erik Fyrwald · CEOLeticia Goncalves Lourenco · PresidentMichael DeVeau · CFOYuvraj Arora · PresidentJennifer Johnson · General CounselBrett Icahn · Independent DirectorCynthia T. Jamison · Independent DirectorDawn C. Willoughby · Independent DirectorJesus B. Mantas · Independent DirectorJohn F. Ferraro · Independent DirectorKathryn J. Boor · Independent DirectorKevin O'Byrne · DirectorMargarita Palau-Hernandez · DirectorMark J. Costa · Independent DirectorMehmood Khan · Independent DirectorPaul J. Fribourg · Independent DirectorRichard Mulligan · Independent DirectorVincent Intrieri · Independent DirectorVirginia C. Drosos · Independent Director
Frequently asked questions
Who was the highest-paid executive at International Flavors & Fragrances Inc in fiscal 2025?
As disclosed, J. Erik Fyrwald (Chief Executive Officer) was the highest-paid executive at International Flavors & Fragrances Inc in fiscal 2025, with total compensation of $15,002,866.
How does International Flavors & Fragrances Inc's chief executive pay compare to its disclosed peer group?
As disclosed, J. Erik Fyrwald's total compensation ranked at the 50th percentile of International Flavors & Fragrances Inc's disclosed peer group.
What is International Flavors & Fragrances Inc's CEO-to-median employee pay ratio?
As disclosed, International Flavors & Fragrances Inc's CEO-to-median employee pay ratio was 239:1.
How did shareholders vote on International Flavors & Fragrances Inc's executive compensation?
As disclosed, 87.25% of shareholders supported International Flavors & Fragrances Inc's executive compensation in the latest say-on-pay vote.
How much does International Flavors & Fragrances Inc spend in total on board compensation for fiscal 2025?
As disclosed, International Flavors & Fragrances Inc reported total board compensation of $3,964,249 for fiscal 2025.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| J. Erik Fyrwald | $1,026,250 | — | $11,656,764 | $0 | $2,047,230 | $164,507 | $108,115 | $15,002,866 |
| Chief Executive Officer | ||||||||
| Leticia Goncalves Lourenco | 566,667 | 1,000,000 | 3,596,668 | 0 | 600,372 | 232 | 45,120 | 5,809,059 |
| President, Health & Biosciences | ||||||||
| Yuvraj Arora | 718,785 | — | 3,199,672 | 0 | 660,904 | 29,638 | 126,690 | 4,735,689 |
| President, Taste | ||||||||
| Jennifer Johnson | 349,153 | — | 1,480,933 | 0 | 266,744 | 6,675 | 1,901,333 | 4,004,838 |
| Former EVP, General Counsel and Corporate Secretary | ||||||||
| Michael DeVeau | 700,000 | — | 2,327,227 | 0 | 623,070 | — | 58,178 | 3,708,475 |
| Chief Financial Officer | ||||||||
| Andres Muller | 615,750 | 325,000 | 2,158,047 | 0 | 459,416 | — | 55,130 | 3,613,343 |
| President, Food Ingredients | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| J. Erik Fyrwald | $15,002,866 | $24,154,267 | — | ↓ −9,151,401 |
| Leticia Goncalves Lourenco | 5,809,059 | — | — | — |
| Yuvraj Arora | 4,735,689 | 3,791,646 | 5,102,547 | ↑ +944,043 |
| Jennifer Johnson | 4,004,838 | 3,075,180 | 2,172,226 | ↑ +929,658 |
| Michael DeVeau | 3,708,475 | — | — | — |
| Andres Muller | 3,613,343 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
Our executive compensation philosophy is that our executives' compensation should be linked to achievement of financial and operating performance metrics that build shareholder value over both the short-term and long-term.
| CEO STI target (% of salary) | 200% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | FW Cook |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | True |
Equity grants and outstanding awards
Grants of plan-based awards — fiscal year 2025
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| J. Erik Fyrwald | PSU | 2025-04-01 | 42,232 | 84,463 | — | 168,926 | $7,296,759 |
| Michael DeVeau | PSU | 2025-04-01 | 7,103 | 14,206 | — | 28,412 | 1,227,256 |
| Andres Muller | PSU | 2025-04-01 | 3,875 | 7,749 | — | 15,498 | 669,436 |
| Michael DeVeau | RSU | 2025-04-01 | — | — | 14,206 | — | 1,099,971 |
| Andres Muller | RSU | 2025-01-02 | — | — | 5,476 | — | 455,001 |
| Jennifer Johnson | RSU | 2025-04-01 | — | — | 9,040 | — | 699,967 |
| Andres Muller | RSU | 2025-04-01 | — | — | 7,749 | — | 600,005 |
| Andres Muller | PSU | 2025-01-02 | 2,496 | 4,992 | — | 9,984 | 456,319 |
| Leticia Gon | RSU | 2025-04-01 | — | — | 9,040 | — | 699,967 |
| Leticia Gonçalves Lourenço | PSU | 2025-04-01 | 4,520 | 9,040 | — | 18,080 | 780,966 |
| Leticia Gonçalves Lourenço | RSU | 2025-04-01 | — | — | 12,915 | — | 1,000,008 |
| Leticia Gon | PSU | 2025-04-01 | 6,458 | 12,915 | — | 25,830 | 1,115,727 |
| Yuvraj Arora | RSU | 2025-04-01 | — | — | 12,915 | — | 1,000,008 |
| Yuvraj Arora | PSU | 2025-04-01 | 6,458 | 12,915 | — | 25,830 | 1,115,727 |
| J. Erik Fyrwald | RSU | 2025-04-01 | — | — | 56,309 | — | 4,360,006 |
| Yuvraj Arora | PSU | 2025-08-01 | 7,197 | 14,393 | — | 28,786 | 1,000,026 |
| Leticia Gon | RSU | 2025-04-01 | — | — | 12,915 | — | 1,000,008 |
| Jennifer Johnson | PSU | 2025-04-01 | 4,520 | 9,040 | — | 18,080 | 780,966 |
| Leticia Gon | PSU | 2025-04-01 | 4,520 | 9,040 | — | 18,080 | 780,966 |
| Leticia Gonçalves Lourenço | PSU | 2025-04-01 | 6,458 | 12,915 | — | 25,830 | 1,115,727 |
| Leticia Gonçalves Lourenço | RSU | 2025-04-01 | — | — | 9,040 | — | 699,967 |
Vehicle mix — grant-date fair value by award type
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| J. Erik Fyrwald | $4,360,006 | $7,296,759 | $0 | 62.6% |
| Michael DeVeau | 1,099,971 | 1,227,256 | 0 | 52.7% |
| Andres Muller | 1,055,006 | 1,125,755 | 0 | 51.6% |
| Jennifer Johnson | 699,967 | 780,966 | 0 | 52.7% |
| Leticia Gon | 1,699,975 | 1,896,693 | 0 | 52.7% |
| Leticia Gonçalves Lourenço | 1,699,975 | 1,896,693 | 0 | 52.7% |
| Yuvraj Arora | 1,000,008 | 2,115,753 | 0 | 67.9% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
Outstanding equity awards at fiscal year-end 2025
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Jennifer Johnson | RSU | 751 | — | $50,610 |
| Michael DeVeau | RSU | 884 | — | 59,573 |
| Jennifer Johnson | RSU | 1,356 | — | 91,381 |
| Jennifer Johnson | RSU | 1,528 | — | 102,972 |
| Michael DeVeau | RSU | 2,221 | — | 149,673 |
| Jennifer Johnson | RSU | 2,221 | — | 149,673 |
| Jennifer Johnson | RSU | 2,694 | — | 181,549 |
| Michael DeVeau | RSU | 2,778 | — | 187,209 |
| Yuvraj Arora | PSU | 5,712 | — | 384,898 |
| Yuvraj Arora | RSU | 6,458 | — | 435,171 |
| Michael DeVeau | RSU | 7,103 | — | 478,671 |
| Yuvraj Arora | RSU | 7,144 | — | 481,434 |
| Yuvraj Arora | RSU | 7,197 | — | 484,972 |
| Yuvraj Arora | RSU | 12,915 | — | 870,342 |
| Michael DeVeau | RSU | 14,206 | — | 957,342 |
| J. Erik Fyrwald | RSU | 31,750 | — | 2,139,633 |
| J. Erik Fyrwald | PSU | 34,375 | — | 2,316,531 |
| J. Erik Fyrwald | RSU | 37,328 | — | 2,515,500 |
| J. Erik Fyrwald | RSU | 42,232 | — | 2,845,981 |
| J. Erik Fyrwald | RSU | 56,250 | — | 3,790,688 |
| J. Erik Fyrwald | RSU | 56,309 | — | 3,794,664 |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Kevin O'ByrneNot independent | $166,667 | $333,354 | $0 | $0 | $7,000 | $507,021 |
| Cynthia T. JamisonIndependent · Audit (Chair) | 125,000 | 199,997 | 0 | 0 | 10,000 | 334,997 |
| Dawn C. WilloughbyIndependent · Governance Corporate Responsibility (Chair) | 120,000 | 199,997 | 0 | 0 | 10,000 | 329,997 |
| John F. FerraroIndependent · Human Capital Compensation (Chair) | 120,000 | 199,997 | 0 | 0 | 10,000 | 329,997 |
| Mehmood KhanIndependent · Innovation (Chair) | 115,000 | 199,997 | 0 | 0 | 0 | 314,997 |
| Mark J. CostaIndependent · Audit · Human Capital & Compensation · Human Capital | 100,000 | 199,997 | 0 | 0 | 0 | 299,997 |
| Kathryn J. BoorIndependent · Governance & Corporate Responsibility · Innovation | 100,000 | 199,997 | 0 | 0 | 0 | 299,997 |
| Virginia C. DrososIndependent · Audit · Human Capital & Compensation · Innovation · Human Capital · Newly elected | 87,671 | 175,335 | 0 | 0 | 0 | 263,006 |
| Vincent IntrieriIndependent | 50,000 | 199,997 | 0 | 0 | 0 | 249,997 |
| Margarita Palau-HernandezNot independent | 50,000 | 199,997 | 0 | 0 | 0 | 249,997 |
| Jesus B. MantasIndependent · Audit · Innovation · Human Capital & Compensation · Newly elected | 75,890 | 151,801 | 0 | 0 | 10,000 | 237,691 |
| Paul J. FribourgIndependent · Audit · Newly elected | 75,890 | 151,801 | 0 | 0 | 0 | 227,691 |
| Brett IcahnIndependent · Audit · Newly elected | 53,151 | 106,281 | 0 | 0 | 0 | 159,432 |
| Richard MulliganIndependent · Innovation · Newly elected | 53,151 | 106,281 | 0 | 0 | 0 | 159,432 |
| J. Erik FyrwaldEmployee director · Innovation | 0 | 0 | 0 | — | 0 | 0 |
Board fee structure and ownership guideline
| Annual cash retainer | $100,000 |
|---|---|
| Annual equity retainer | $200,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 25,000 / 20,000 / 20,000 |
| Stock ownership guideline | $500,000 |
Total cost of the board
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $1,292,420 |
| Equity awards (grant-date value) | $2,624,829 |
| All other compensation | $47,000 |
| Total cost of the board | $3,964,249 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names International Flavors & Fragrances as a peer
Companies that benchmark against IFF
18 companies name IFF as a compensation peer
- Amcor plcAMCRFY2026
- APTARGROUP, INC.ATRFY2025
- Avery Dennison CorpAVYFY2024
- Axalta Coating Systems Ltd.AXTAFY2025
- BALL CorpBALLFY2025
- Celanese CorpCEFY2025
- CF Industries Holdings, Inc.CFFY2025
- Corteva, Inc.CTVAFY2025
- DARLING INGREDIENTS INC.DARFY2025
- EASTMAN CHEMICAL COEMNFY2025
- ESTEE LAUDER COMPANIES INCELFY2026
- FMC CORPFMCFY2025
- FULLER H B COFULFY2025
- HERBALIFE LTD.HLFFY2025
- Ingredion IncINGRFY2025
- MCCORMICK & CO INCMKCFY2025
- OLIN CorpOLNFY2025
- SEMPRASREFY2025
Each company listed discloses IFF in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named IFF in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
Disclosed peer group — fiscal year 2025
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
BHC Bausch Health Companies Inc.CE Celanese CorporationCLX The Clorox CompanyCL Colgate-Palmolive CompanyCTVA Corteva, Inc.ECL Ecolab Inc.GIS General Mills, Inc.KMB Kimberly-Clark CorporationMKC McCormick & Company, Inc.VTRS Viatris Inc.ZTS ZoetisADM Archer-Daniels Midland CompanySTZ Constellation Brands, Inc.CHD Church & Dwight Co., Inc.INGR Ingredion IncorporatedEL The Estée Lauder Companies Inc.CTLT Catalent, Inc.BALL Ball CorporationHSY The Hershey CompanyKDP Keurig Dr Pepper Inc.
Peer reciprocity
Of the companies International Flavors & Fragrances Inc names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
— Bausch Health Companies Inc. (BHC)183✓ Celanese Corporation (CE)184— The Clorox Company (CLX)185 Colgate-Palmolive Company (CL)✓ Corteva, Inc. (CTVA)186— Ecolab Inc. (ECL)187— General Mills, Inc. (GIS)188 Kimberly-Clark Corporation (KMB)✓ McCormick & Company, Inc. (MKC)189— Viatris Inc. (VTRS)190— Zoetis (ZTS)191 Archer-Daniels Midland Company (ADM)— Constellation Brands, Inc. (STZ)192 Church & Dwight Co., Inc. (CHD)✓ Ingredion Incorporated (INGR)193✓ The Estée Lauder Companies Inc. (EL)194— Catalent, Inc. (CTLT)195✓ Ball Corporation (BALL)196— The Hershey Company (HSY)197— Keurig Dr Pepper Inc. (KDP)198
Reciprocity shown where the peer’s own current proxy has been read — each mark is cited in the register to that peer’s filing. A dash means the peer’s current proxy was read and names no reciprocal group including International Flavors & Fragrances Inc.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Archer-Daniels Midland Company | 2025 | Juan Luciano | $1,492,500 | $17,700,055 | $0 | $2,826,795 | $23,886,978 |
| 2 | The Estée Lauder Companies Inc. | 2026 | Stéphane Faverie | 1,500,000 | 8,396,680 | 6,325,072 | 4,105,300 | 20,585,784 |
| 3 | Zoetis | 2025 | Kristin Peck | 1,350,000 | 10,218,583 | 3,406,229 | 2,187,000 | 19,046,509 |
| 4 | Corteva, Inc. | 2025 | Charles Magro | 1,405,385 | 9,320,078 | 2,330,023 | 3,990,000 | 17,499,399 |
| 5 | Ecolab Inc. | 2025 | Christophe Beck | 1,390,081 | 7,228,101 | 4,566,916 | 3,383,183 | 17,404,935 |
| 6 | Bausch Health Companies Inc. | 2025 | Thomas Appio | 1,236,000 | 13,032,562 | 0 | 2,336,000 | 16,877,326 |
| 7 | The Hershey Company | 2025 | Kirk Tanner | 456,731 | 14,674,113 | 0 | 1,358,052 | 16,806,399 |
| 8 | Colgate-Palmolive Company | 2025 | Noel Wallace | 1,500,000 | 8,005,152 | 3,570,016 | 2,455,950 | 16,478,196 |
| 9 | Kimberly-Clark Corporation | 2025 | Michael Hsu | 1,500,000 | 11,499,989 | 0 | 1,596,424 | 15,320,405 |
| 10 | Viatris Inc. | 2025 | Scott Smith | 1,448,654 | 10,150,013 | 0 | 2,973,660 | 15,273,331 |
| 11 | International Flavors & Fragrances Inc | 2025 | J. Erik Fyrwald | 1,026,250 | 11,656,764 | 0 | 2,047,230 | 15,002,866 |
| 12 | Constellation Brands, Inc. | 2026 | William Newlands | 1,449,038 | 10,767,749 | 0 | 1,564,382 | 14,209,126 |
| 13 | General Mills, Inc. | 2026 | Jeffrey Harmening | 1,350,000 | 7,326,405 | 2,279,973 | 1,404,540 | 14,018,052 |
| 14 | The Clorox Company | 2026 | Linda Rendle | 1,344,231 | 10,699,895 | 0 | 1,202,850 | 14,000,460 |
| 15 | Ball Corporation | 2025 | Daniel Fisher | 1,269,462 | 5,798,801 | 2,081,242 | 3,676,886 | 13,486,942 |
| 16 | Ingredion Incorporated | 2025 | James Zallie | 1,290,929 | 6,509,237 | 1,999,964 | 2,185,980 | 12,932,234 |
| 17 | McCormick & Company, Inc. | 2025 | Brendan Foley | 1,139,084 | 8,600,105 | 0 | 720,130 | 10,831,581 |
| 18 | Celanese Corporation | 2025 | Scott Richardson | — | 5,249,958 | 2,249,990 | 1,342,625 | 10,137,072 |
| 19 | Church & Dwight Co., Inc. | 2025 | Richard Dierker | 986,580 | 1,770,973 | 5,313,100 | 1,472,656 | 9,799,678 |
| 20 | Keurig Dr Pepper Inc. | 2025 | Timothy Cofer | 1,331,923 | 5,125,514 | 0 | 1,719,234 | 8,217,032 |
| 21 | Catalent, Inc. | 2023 | Alessandro Maselli | 925,000 | 3,850,216 | 1,650,019 | 0 | 6,583,672 |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Incentive design against the same peers
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| International Flavors & Fragrances Inc | 98.9% | PSU 60 · RSU 40 | Yes — Relative TSR vs. S&P 500 - Chemicals | FW Cook |
| Archer-Daniels Midland Company | 94.7% | PSU 60 · RSU 40 | No | Meridian Compensation Partners, LLC |
| Ball Corporation | 150% | PSU 50 · Options 25 · RSU 25 | Yes — Relative Total Shareholder Return (rTSR) | Farient Advisors LLC |
| Bausch Health Companies Inc. | 126% | PSU 60 · RSU 40 | Yes — Relative Total Shareholder Return (rTSR) | Pay Governance |
| Catalent, Inc. | 0% | PSU 50 · Option 30 · RSU 20 | No | Frederic W. Cook & Co., Inc. |
| Celanese Corporation | 93.4% | PSU 70 · Options 30 | No | Willis Towers Watson PLC |
| Church & Dwight Co., Inc. | 125% | Options 75 · PSU 15 · RSU 10 | No | Semler Brossy Consulting Group |
| Colgate-Palmolive Company | 93.6% | PSU 50 · Options 30 · RSU 20 | No | FW Cook |
| Constellation Brands, Inc. | 54% | RSU 50 · PSU 50 | Yes — Relative TSR | FW Cook |
| Corteva, Inc. | 190.0% | PSU 60 · Option 20 · RSU 20 | No | Frederic W. Cook & Co., Inc. |
| Ecolab Inc. | 137% | PSU 60 · Options 40 | Yes — relative TSR | FW Cook |
| General Mills, Inc. | 58% | PSU 50 · RSU 25 · Option 25 | Yes — Relative TSR Modifier | FW Cook |
| Ingredion Incorporated | 112.5% | PSU 50 · RSU 25 · Options 25 | Yes — Relative Total Shareholder Return (rTSR) | Meridian |
| Keurig Dr Pepper Inc. | 86% | RSU 75 · PSU 25 | No | FW Cook |
| Kimberly-Clark Corporation | 61% | PSU 60 · RSU 40 | No | Semler Brossy Consulting Group |
| McCormick & Company, Inc. | 40.4% | PSU 50 · RSU 50 | Yes — McCormick's TSR relative to the TSR generated by our Peer Group companies | WTW (Willis Towers Watson) |
| The Clorox Company | 54% | PSU 60 · RSU 40 | No | FW Cook |
| The Estée Lauder Companies Inc. | not disclosed | Options 60 · RSU 40 | not disclosed | Semler Brossy Consulting Group, LLC |
| The Hershey Company | not disclosed | PSU 65 · RSU 35 | No | F.W. Cook |
| Viatris Inc. | 136.72% | PSU 65 · RSU 35 | No | Meridian Compensation Partners, LLC |
| Zoetis | 108% | PSU 50 · Options 25 · RSU 25 | Yes — Relative TSR | Pearl Meyer |
Read from each company’s Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company’s filing does not state the item.
Say-on-pay history and pay ratio
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-04-29 | 199,852,600 | 29,195,584 | 135,226 | 87.25% | Passed |
| 2025 | 2025-05-01 | 187,853,527 | 33,680,007 | 206,512 | 84.8% | Passed |
| 2024 | 2024-05-01 | 207,742,404 | 13,502,197 | 186,919 | 93.9% | Passed |
| 2023 | 2023-05-03 | 196,559,195 | 23,864,597 | 237,229 | 89.17% | Passed |
| 2022 | 2022-05-04 | 200,700,803 | 14,389,613 | 177,269 | 93.31% | Passed |
| 2021 | 2021-05-05 | 188,719,251 | 17,116,403 | 477,493 | 91.68% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.
Say-on-pay — history, company’s computation
| Meeting year | Meeting date | Approval — company’s computation |
|---|---|---|
| 2026 | 2026-04-29 | 87.25%a |
| 2025 | 2025-05-01 | 84.8%b |
| 2024 | 2024-05-01 | 93.9%c |
a. Approved under the standard stated in the filing — “Abstentions are not counted as votes "FOR" or "AGAINST" this proposal and will have no effect on the outcome of this proposal.”.
b. Approved under the standard stated in the filing — “Abstentions are not counted as votes "FOR" or "AGAINST" this proposal and will have no effect on the outcome of this proposal.”.
c. Approved under the standard stated in the filing — “Abstentions are not counted as votes "FOR" or "AGAINST" this proposal and will have no effect on the outcome of this proposal.”.
Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
CEO pay ratio
| Ratio (CEO : median employee) | 239 : 1 |
|---|---|
| CEO total compensation | $15,002,866 |
| Median employee compensation | $62,828 |
Insider trades since the proxy
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Teles de Mendonca Ana Paula | President, Scent | 2026-04-01 | D | 2,583 | $73 | $187,448 | Derivative, Class A Common | Form 4 ↗ |
| Marc Birenkrant | Controller & CAO | 2026-04-01 | D | 473 | 73 | 34,326 | Derivative, Class A Common | Form 4 ↗ |
| Yuvraj Arora | President, Taste & CCO | 2026-04-01 | D | 4,305 | 73 | 312,414 | Derivative, Class A Common | Form 4 ↗ |
| Yuvraj Arora | President, Taste & CCO | 2026-04-01 | A | 4,305 | 0 | 0 | Common | Form 4 ↗ |
| Teles de Mendonca Ana Paula | President, Scent | 2026-04-01 | A | 12,402 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Teles de Mendonca Ana Paula | President, Scent | 2026-04-01 | D | 932 | 73 | 67,635 | Common | Form 4 ↗ |
| Teles de Mendonca Ana Paula | President, Scent | 2026-04-01 | A | 2,583 | 0 | 0 | Common | Form 4 ↗ |
| Michael DeVeau | EVP, CFO | 2026-04-01 | A | 16,536 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Stephen N. Landsman | EVP, General Counsel | 2026-04-01 | D | 3,228 | 73 | 234,256 | Derivative, Class A Common | Form 4 ↗ |
| Stephen N. Landsman | EVP, General Counsel | 2026-04-01 | A | 15,158 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Deborah Borg | EVP, Chief Ppl&Culture Officer | 2026-04-01 | A | 2,030 | 0 | 0 | Common | Form 4 ↗ |
| Marc Birenkrant | Controller & CAO | 2026-04-01 | A | 473 | 0 | 0 | Common | Form 4 ↗ |
| Leticia Goncalves Lourenco | President, Health & Bioscience | 2026-04-01 | A | 3,013 | 0 | 0 | Common | Form 4 ↗ |
| Leticia Goncalves Lourenco | President, Health & Bioscience | 2026-04-01 | A | 4,305 | 0 | 0 | Common | Form 4 ↗ |
| Ralf Finzel | EVP, Global Operations Officer | 2026-04-01 | D | 2,152 | 73 | 156,171 | Derivative, Class A Common | Form 4 ↗ |
| Ralf Finzel | EVP, Global Operations Officer | 2026-04-01 | A | 2,152 | 0 | 0 | Common | Form 4 ↗ |
| Ralf Finzel | EVP, Global Operations Officer | 2026-04-01 | A | 6,890 | — | — | Derivative, Class A Common | Form 4 ↗ |
| J. Erik Fyrwald | Director | 2026-04-01 | A | 66,143 | — | — | Derivative, Class A Common | Form 4 ↗ |
| J. Erik Fyrwald | Director | 2026-04-01 | D | 18,769 | 73 | 1,362,066 | Derivative, Class A Common | Form 4 ↗ |
| J. Erik Fyrwald | Director | 2026-04-01 | D | 8,835 | 73 | 641,156 | Common | Form 4 ↗ |
| J. Erik Fyrwald | Director | 2026-04-01 | A | 18,769 | 0 | 0 | Common | Form 4 ↗ |
| Yuvraj Arora | President, Taste & CCO | 2026-04-01 | A | 13,780 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Michael DeVeau | EVP, CFO | 2026-04-01 | D | 2,418 | 73 | 175,474 | Common | Form 4 ↗ |
| Deborah Borg | EVP, Chief Ppl&Culture Officer | 2026-04-01 | D | 2,030 | 73 | 147,317 | Derivative, Class A Common | Form 4 ↗ |
| Leticia Goncalves Lourenco | President, Health & Bioscience | 2026-04-01 | D | 4,305 | 73 | 312,414 | Derivative, Class A Common | Form 4 ↗ |
| Ralf Finzel | EVP, Global Operations Officer | 2026-04-01 | D | 868 | 73 | 62,991 | Common | Form 4 ↗ |
| Michael DeVeau | EVP, CFO | 2026-04-01 | D | 4,735 | 73 | 343,619 | Derivative, Class A Common | Form 4 ↗ |
| Deborah Borg | EVP, Chief Ppl&Culture Officer | 2026-04-01 | D | 819 | 73 | 59,435 | Common | Form 4 ↗ |
| Andres Muller | President, Food Ingredients | 2026-04-01 | D | 759 | 73 | 55,081 | Common | Form 4 ↗ |
| Yuvraj Arora | President, Taste & CCO | 2026-04-01 | D | 2,203 | 73 | 159,872 | Common | Form 4 ↗ |
| Stephen N. Landsman | EVP, General Counsel | 2026-04-01 | D | 1,164 | 73 | 84,471 | Common | Form 4 ↗ |
| Deborah Borg | EVP, Chief Ppl&Culture Officer | 2026-04-01 | A | 11,024 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Andres Muller | President, Food Ingredients | 2026-04-01 | A | 12,402 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Michael DeVeau | EVP, CFO | 2026-04-01 | A | 4,735 | 0 | 0 | Common | Form 4 ↗ |
| Stephen N. Landsman | EVP, General Counsel | 2026-04-01 | A | 3,228 | 0 | 0 | Common | Form 4 ↗ |
| Andres Muller | President, Food Ingredients | 2026-04-01 | D | 2,583 | 73 | 187,448 | Derivative, Class A Common | Form 4 ↗ |
| Andres Muller | President, Food Ingredients | 2026-04-01 | A | 2,583 | 0 | 0 | Common | Form 4 ↗ |
| Marc Birenkrant | Controller & CAO | 2026-04-01 | A | 2,480 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Marc Birenkrant | Controller & CAO | 2026-04-01 | D | 171 | 73 | 12,409 | Common | Form 4 ↗ |
| Leticia Goncalves Lourenco | President, Health & Bioscience | 2026-04-01 | D | 3,013 | 73 | 218,653 | Derivative, Class A Common | Form 4 ↗ |
| Leticia Goncalves Lourenco | President, Health & Bioscience | 2026-04-01 | A | 13,780 | — | — | Derivative, Class A Common | Form 4 ↗ |
| Leticia Goncalves Lourenco | President, Health & Bioscience | 2026-04-01 | D | 1,908 | 73 | 138,464 | Common | Form 4 ↗ |
| Leticia Goncalves Lourenco | President, Health & Bioscience | 2026-04-01 | D | 1,335 | 73 | 96,881 | Common | Form 4 ↗ |
| Virginia C. Drosos | Director | 2026-04-29 | A | 2,903 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Paul J. Fribourg | Director | 2026-04-29 | A | 2,903 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Brett Icahn | Director | 2026-04-29 | A | 2,903 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jesus B. Mantas | Director | 2026-04-29 | A | 2,903 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Richard Mulligan | Director | 2026-04-29 | A | 2,903 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kevin O'Byrne | Director | 2026-04-29 | A | 4,839 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Cynthia T. Jamison | Director | 2026-04-29 | A | 2,903 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Dawn C. Willoughby | Director | 2026-04-29 | A | 2,903 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Mehmood Khan | Director | 2026-04-29 | A | 2,903 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yuvraj Arora | President, Taste & CCO | 2026-05-01 | D | 3,572 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Yuvraj Arora | President, Taste & CCO | 2026-05-01 | A | 3,572 | 0 | 0 | Common | Form 4 ↗ |
| Deborah Borg | EVP, Chief Ppl&Culture Officer | 2026-05-01 | D | 2,381 | 71 | 168,599 | Derivative, Class A Common | Form 4 ↗ |
| Deborah Borg | EVP, Chief Ppl&Culture Officer | 2026-05-01 | D | 960 | 71 | 67,978 | Common | Form 4 ↗ |
| Deborah Borg | EVP, Chief Ppl&Culture Officer | 2026-05-01 | A | 2,381 | 0 | 0 | Common | Form 4 ↗ |
| Ralf Finzel | EVP, Global Operations Officer | 2026-05-01 | D | 1,984 | 71 | 140,487 | Derivative, Class A Common | Form 4 ↗ |
| Ralf Finzel | EVP, Global Operations Officer | 2026-05-01 | D | 1,098 | 71 | 77,749 | Common | Form 4 ↗ |
| Ralf Finzel | EVP, Global Operations Officer | 2026-05-01 | A | 1,984 | 0 | 0 | Common | Form 4 ↗ |
| J. Erik Fyrwald | Director | 2026-05-01 | D | 15,875 | 71 | 1,124,109 | Derivative, Class A Common | Form 4 ↗ |
| J. Erik Fyrwald | Director | 2026-05-01 | A | 15,875 | 0 | 0 | Common | Form 4 ↗ |
| Marc Birenkrant | Controller & CAO | 2026-05-01 | D | 397 | 71 | 28,112 | Derivative, Class A Common | Form 4 ↗ |
| Marc Birenkrant | Controller & CAO | 2026-05-01 | D | 144 | 71 | 10,197 | Common | Form 4 ↗ |
| Marc Birenkrant | Controller & CAO | 2026-05-01 | A | 397 | 0 | 0 | Common | Form 4 ↗ |
| Teles de Mendonca Ana Paula | President, Scent | 2026-05-01 | D | 1,587 | 71 | 112,375 | Derivative, Class A Common | Form 4 ↗ |
| Teles de Mendonca Ana Paula | President, Scent | 2026-05-01 | D | 625 | 71 | 44,256 | Common | Form 4 ↗ |
| Teles de Mendonca Ana Paula | President, Scent | 2026-05-01 | A | 1,587 | 0 | 0 | Common | Form 4 ↗ |
| Virginia C. Drosos | Director | 2026-05-01 | D | 2,335 | 71 | 165,341 | Derivative, Class A Common | Form 4 ↗ |
| Virginia C. Drosos | Director | 2026-05-01 | A | 2,335 | 0 | 0 | Common | Form 4 ↗ |
| Brett Icahn | Director | 2026-05-01 | A | 1,712 | 0 | 0 | Common | Form 4 ↗ |
| Richard Mulligan | Director | 2026-05-01 | A | 1,712 | 0 | 0 | Common | Form 4 ↗ |
| Kevin O'Byrne | Director | 2026-05-01 | A | 4,282 | 0 | 0 | Common | Form 4 ↗ |
| Jesus B. Mantas | Director | 2026-05-01 | A | 2,281 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jesus B. Mantas | Director | 2026-05-01 | D | 2,281 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Cynthia T. Jamison | Director | 2026-05-01 | A | 2,569 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Cynthia T. Jamison | Director | 2026-05-01 | D | 2,569 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Dawn C. Willoughby | Director | 2026-05-01 | A | 2,569 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Dawn C. Willoughby | Director | 2026-05-01 | D | 2,569 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Paul J. Fribourg | Director | 2026-05-01 | A | 2,281 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Paul J. Fribourg | Director | 2026-05-01 | D | 2,281 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Michael DeVeau | EVP, CFO | 2026-05-01 | D | 710 | 71 | 50,275 | Common | Form 4 ↗ |
| Richard Mulligan | Director | 2026-05-01 | D | 1,712 | 71 | 121,227 | Derivative, Class A Common | Form 4 ↗ |
| Yuvraj Arora | President, Taste & CCO | 2026-05-01 | D | 1,828 | 71 | 129,441 | Common | Form 4 ↗ |
| Michael DeVeau | EVP, CFO | 2026-05-01 | D | 1,389 | 71 | 98,355 | Derivative, Class A Common | Form 4 ↗ |
| Mehmood Khan | Director | 2026-05-01 | A | 2,569 | 0 | 0 | Common | Form 4 ↗ |
| Brett Icahn | Director | 2026-05-01 | D | 1,712 | 71 | 121,227 | Derivative, Class A Common | Form 4 ↗ |
| Mehmood Khan | Director | 2026-05-01 | D | 2,569 | 71 | 181,911 | Derivative, Class A Common | Form 4 ↗ |
| Kevin O'Byrne | Director | 2026-05-01 | D | 4,282 | 71 | 303,208 | Derivative, Class A Common | Form 4 ↗ |
| Kevin O'Byrne | Director | 2026-05-01 | D | 1,157 | 71 | 81,927 | Common | Form 4 ↗ |
| Michael DeVeau | EVP, CFO | 2026-05-01 | A | 1,389 | 0 | 0 | Common | Form 4 ↗ |
| J. Erik Fyrwald | Director | 2026-05-01 | D | 7,763 | 71 | 549,698 | Common | Form 4 ↗ |
| Deborah Borg | EVP, Chief Ppl&Culture Officer | 2026-05-04 | D | 713 | 70 | 49,974 | Common | Form 4 ↗ |
| Deborah Borg | EVP, Chief Ppl&Culture Officer | 2026-05-04 | A | 1,768 | 0 | 0 | Common | Form 4 ↗ |
| Michael DeVeau | EVP, CFO | 2026-05-04 | A | 884 | 0 | 0 | Common | Form 4 ↗ |
| Ralf Finzel | EVP, Global Operations Officer | 2026-05-04 | D | 1,326 | 70 | 92,939 | Derivative, Class A Common | Form 4 ↗ |
| Ralf Finzel | EVP, Global Operations Officer | 2026-05-04 | D | 734 | 70 | 51,446 | Common | Form 4 ↗ |
| Marc Birenkrant | Controller & CAO | 2026-05-04 | A | 389 | 0 | 0 | Common | Form 4 ↗ |
| Michael DeVeau | EVP, CFO | 2026-05-04 | D | 884 | 70 | 61,960 | Derivative, Class A Common | Form 4 ↗ |
| Marc Birenkrant | Controller & CAO | 2026-05-04 | D | 141 | 70 | 9,883 | Common | Form 4 ↗ |
| Ralf Finzel | EVP, Global Operations Officer | 2026-05-04 | A | 1,326 | 0 | 0 | Common | Form 4 ↗ |
| Michael DeVeau | EVP, CFO | 2026-05-04 | D | 452 | 70 | 31,681 | Common | Form 4 ↗ |
| Teles de Mendonca Ana Paula | President, Scent | 2026-05-04 | D | 362 | 70 | 25,373 | Common | Form 4 ↗ |
| Marc Birenkrant | Controller & CAO | 2026-05-04 | D | 389 | 70 | 27,265 | Derivative, Class A Common | Form 4 ↗ |
| Deborah Borg | EVP, Chief Ppl&Culture Officer | 2026-05-04 | D | 1,768 | 70 | 123,919 | Derivative, Class A Common | Form 4 ↗ |
| Teles de Mendonca Ana Paula | President, Scent | 2026-05-04 | D | 708 | 70 | 49,624 | Derivative, Class A Common | Form 4 ↗ |
| Teles de Mendonca Ana Paula | President, Scent | 2026-05-04 | A | 708 | 0 | 0 | Common | Form 4 ↗ |
| Paul J. Fribourg | Director | 2026-06-01 | A | 13,500 | 74 | 1,005,575 | Common | Form 4 ↗ |
| Paul J. Fribourg | Director | 2026-06-01 | A | 260,000 | 74 | 19,312,280 | Common | Form 4 ↗ |
| Michael DeVeau | EVP, CFO | 2026-08-06 | D | 8,825 | 86 | 754,970 | Common | Form 4 ↗ |
| Marc Birenkrant | Controller & CAO | 2026-08-07 | D | 1,000 | 85 | 85,000 | Common | Form 4 ↗ |
| Teles de Mendonca Ana Paula | President, Scent | 2026-08-17 | D | 5,718 | 83 | 475,692 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
Sources (198 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, J. Erik Fyrwald. DEF 14A, filed 2026-03-18. Section “Summary Compensation Table” · page 50. As printed: 15,002,866. View filing ↗
- Section 01, Leticia Goncalves Lourenco. DEF 14A, filed 2026-03-18. Section “Executive Compensation”. As printed: 5,809,059. View filing ↗
- Section 01, Yuvraj Arora. DEF 14A, filed 2026-03-18. Section “Summary Compensation Table” · page 50. As printed: 4,735,689. View filing ↗
- Section 01, Jennifer Johnson. DEF 14A, filed 2026-03-18. Section “Summary Compensation Table” · page 50. As printed: 4,004,838. View filing ↗
- Section 01, Michael DeVeau. DEF 14A, filed 2026-03-18. Section “Summary Compensation Table” · page 50. As printed: 3,708,475. View filing ↗
- Section 01, Andres Muller. DEF 14A, filed 2026-03-18. Section “Summary Compensation Table” · page 50. As printed: 3,613,343. View filing ↗
- Section 03, J. Erik Fyrwald PSU. DEF 14A, filed 2026-03-18. Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Michael DeVeau PSU. DEF 14A, filed 2026-03-18. Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Andres Muller PSU. DEF 14A, filed 2026-03-18. Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Michael DeVeau RSU. DEF 14A, filed 2026-03-18. Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Andres Muller RSU. DEF 14A, filed 2026-03-18. Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Jennifer Johnson RSU. DEF 14A, filed 2026-03-18. Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Andres Muller RSU. DEF 14A, filed 2026-03-18. Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Andres Muller PSU. DEF 14A, filed 2026-03-18. Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Leticia Gon RSU. DEF 14A, filed 2026-03-18. Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Leticia Gonçalves Lourenço PSU. DEF 14A, filed 2026-03-18. Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Leticia Gonçalves Lourenço RSU. DEF 14A, filed 2026-03-18. Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Leticia Gon PSU. DEF 14A, filed 2026-03-18. Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Yuvraj Arora RSU. DEF 14A, filed 2026-03-18. Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Yuvraj Arora PSU. DEF 14A, filed 2026-03-18. Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, J. Erik Fyrwald RSU. DEF 14A, filed 2026-03-18. Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Yuvraj Arora PSU. DEF 14A, filed 2026-03-18. Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Leticia Gon RSU. DEF 14A, filed 2026-03-18. Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Jennifer Johnson PSU. DEF 14A, filed 2026-03-18. Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Leticia Gon PSU. DEF 14A, filed 2026-03-18. Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Leticia Gonçalves Lourenço PSU. DEF 14A, filed 2026-03-18. Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Leticia Gonçalves Lourenço RSU. DEF 14A, filed 2026-03-18. Section “2025 Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 07, pay ratio. DEF 14A, filed 2026-03-18. Section “CEO Pay Ratio”. As printed: 239 : 1. View filing ↗
- Section 08, Kevin O'Byrne. DEF 14A, filed 2026-03-18. Section “Director Compensation”. As printed: 507,021. View filing ↗
- Section 08, Cynthia T. Jamison. DEF 14A, filed 2026-03-18. Section “Director Compensation”. As printed: 334,997. View filing ↗
- Section 08, Dawn C. Willoughby. DEF 14A, filed 2026-03-18. Section “Director Compensation”. As printed: 329,997. View filing ↗
- Section 08, John F. Ferraro. DEF 14A, filed 2026-03-18. Section “Director Compensation”. As printed: 329,997. View filing ↗
- Section 08, Mehmood Khan. DEF 14A, filed 2026-03-18. Section “Director Compensation”. As printed: 314,997. View filing ↗
- Section 08, Mark J. Costa. DEF 14A, filed 2026-03-18. Section “Director Compensation”. As printed: 299,997. View filing ↗
- Section 08, Kathryn J. Boor. DEF 14A, filed 2026-03-18. Section “Director Compensation”. As printed: 299,997. View filing ↗
- Section 08, Virginia C. Drosos. DEF 14A, filed 2026-03-18. Section “Director Compensation”. As printed: 263,006. View filing ↗
- Section 08, Vincent Intrieri. DEF 14A, filed 2026-03-18. Section “Director Compensation”. As printed: 249,997. View filing ↗
- Section 08, Margarita Palau-Hernandez. DEF 14A, filed 2026-03-18. Section “Director Compensation”. As printed: 249,997. View filing ↗
- Section 08, Jesus B. Mantas. DEF 14A, filed 2026-03-18. Section “Director Compensation”. As printed: 237,691. View filing ↗
- Section 08, Paul J. Fribourg. DEF 14A, filed 2026-03-18. Section “Director Compensation”. As printed: 227,691. View filing ↗
- Section 08, Brett Icahn. DEF 14A, filed 2026-03-18. Section “Director Compensation”. As printed: 159,432. View filing ↗
- Section 08, Richard Mulligan. DEF 14A, filed 2026-03-18. Section “Director Compensation”. As printed: 159,432. View filing ↗
- Section 08, J. Erik Fyrwald. DEF 14A, filed 2026-03-18. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 02, Teles de Mendonca Ana Paula 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Marc Birenkrant 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yuvraj Arora 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yuvraj Arora 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Teles de Mendonca Ana Paula 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Teles de Mendonca Ana Paula 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Teles de Mendonca Ana Paula 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Michael DeVeau 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen N. Landsman 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen N. Landsman 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Deborah Borg 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Marc Birenkrant 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Leticia Goncalves Lourenco 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Leticia Goncalves Lourenco 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ralf Finzel 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ralf Finzel 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ralf Finzel 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, J. Erik Fyrwald 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, J. Erik Fyrwald 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, J. Erik Fyrwald 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, J. Erik Fyrwald 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yuvraj Arora 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Michael DeVeau 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Deborah Borg 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Leticia Goncalves Lourenco 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ralf Finzel 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Michael DeVeau 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Deborah Borg 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Andres Muller 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yuvraj Arora 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen N. Landsman 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Deborah Borg 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Andres Muller 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Michael DeVeau 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Stephen N. Landsman 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Andres Muller 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Andres Muller 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Marc Birenkrant 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Marc Birenkrant 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Leticia Goncalves Lourenco 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Leticia Goncalves Lourenco 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Leticia Goncalves Lourenco 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Leticia Goncalves Lourenco 2026-04-01. Form 4, filed 2026-04-03. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Virginia C. Drosos 2026-04-29. Form 4, filed 2026-04-30. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Paul J. Fribourg 2026-04-29. Form 4, filed 2026-04-30. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Brett Icahn 2026-04-29. Form 4, filed 2026-04-30. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jesus B. Mantas 2026-04-29. Form 4, filed 2026-04-30. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard Mulligan 2026-04-29. Form 4, filed 2026-04-30. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kevin O'Byrne 2026-04-29. Form 4, filed 2026-04-30. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Cynthia T. Jamison 2026-04-29. Form 4, filed 2026-04-30. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Dawn C. Willoughby 2026-04-29. Form 4, filed 2026-04-30. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mehmood Khan 2026-04-29. Form 4, filed 2026-04-30. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yuvraj Arora 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yuvraj Arora 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Deborah Borg 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Deborah Borg 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Deborah Borg 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ralf Finzel 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ralf Finzel 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ralf Finzel 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, J. Erik Fyrwald 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, J. Erik Fyrwald 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Marc Birenkrant 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Marc Birenkrant 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Marc Birenkrant 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Teles de Mendonca Ana Paula 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Teles de Mendonca Ana Paula 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Teles de Mendonca Ana Paula 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Virginia C. Drosos 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Virginia C. Drosos 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Brett Icahn 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard Mulligan 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kevin O'Byrne 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jesus B. Mantas 2026-05-01. Form 4, filed 2026-05-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jesus B. Mantas 2026-05-01. Form 4, filed 2026-05-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Cynthia T. Jamison 2026-05-01. Form 4, filed 2026-05-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Cynthia T. Jamison 2026-05-01. Form 4, filed 2026-05-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Dawn C. Willoughby 2026-05-01. Form 4, filed 2026-05-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Dawn C. Willoughby 2026-05-01. Form 4, filed 2026-05-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Paul J. Fribourg 2026-05-01. Form 4, filed 2026-05-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Paul J. Fribourg 2026-05-01. Form 4, filed 2026-05-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Michael DeVeau 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Richard Mulligan 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Yuvraj Arora 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Michael DeVeau 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mehmood Khan 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Brett Icahn 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mehmood Khan 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kevin O'Byrne 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kevin O'Byrne 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Michael DeVeau 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, J. Erik Fyrwald 2026-05-01. Form 4, filed 2026-05-04. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Deborah Borg 2026-05-04. Form 4, filed 2026-05-06. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Deborah Borg 2026-05-04. Form 4, filed 2026-05-06. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Michael DeVeau 2026-05-04. Form 4, filed 2026-05-06. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ralf Finzel 2026-05-04. Form 4, filed 2026-05-06. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ralf Finzel 2026-05-04. Form 4, filed 2026-05-06. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Marc Birenkrant 2026-05-04. Form 4, filed 2026-05-06. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Michael DeVeau 2026-05-04. Form 4, filed 2026-05-06. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Marc Birenkrant 2026-05-04. Form 4, filed 2026-05-06. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ralf Finzel 2026-05-04. Form 4, filed 2026-05-06. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Michael DeVeau 2026-05-04. Form 4, filed 2026-05-06. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Teles de Mendonca Ana Paula 2026-05-04. Form 4, filed 2026-05-06. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Marc Birenkrant 2026-05-04. Form 4, filed 2026-05-06. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Deborah Borg 2026-05-04. Form 4, filed 2026-05-06. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Teles de Mendonca Ana Paula 2026-05-04. Form 4, filed 2026-05-06. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Teles de Mendonca Ana Paula 2026-05-04. Form 4, filed 2026-05-06. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Paul J. Fribourg 2026-06-01. Form 4, filed 2026-06-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Paul J. Fribourg 2026-06-01. Form 4, filed 2026-06-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Michael DeVeau 2026-08-06. Form 4, filed 2026-08-07. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Marc Birenkrant 2026-08-07. Form 4, filed 2026-08-10. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Teles de Mendonca Ana Paula 2026-08-17. Form 4, filed 2026-08-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 06, 2026 vote. Form 8-K, filed 2026-05-04. Item 5.07 · say-on-pay result. As reported: 87.25% (votes for as printed: 199,852,600). View filing ↗
- Section 06, 2025 vote. Form 8-K, filed 2025-05-07. Item 5.07 · say-on-pay result. As reported: 84.8% (votes for as printed: 187,853,527). View filing ↗
- Section 06, 2024 vote. Form 8-K, filed 2024-05-07. Item 5.07 · say-on-pay result. As reported: 93.9% (votes for as printed: 207,742,404). View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
- Section 09b board cost (computed). Computed. Cash 1,292,420 + equity 2,624,829 + all other 47,000 = 3,964,249, summed across the director compensation table rows.
- Archer-Daniels Midland Company, Section 10b CEO total. DEF 14A, filed 2026-03-26. CEO total compensation as printed in Archer-Daniels Midland Company's own proxy. As printed: 23,886,978. View filing ↗
- The Estée Lauder Companies Inc., Section 10b CEO total. DEF 14A, filed 2026-09-30. CEO total compensation as printed in The Estée Lauder Companies Inc.'s own proxy. As printed: 20,585,784. View filing ↗
- Zoetis, Section 10b CEO total. DEF 14A, filed 2026-04-08. CEO total compensation as printed in Zoetis's own proxy. As printed: 19,046,509. View filing ↗
- Corteva, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-19. CEO total compensation as printed in Corteva, Inc.'s own proxy. As printed: 17,499,399. View filing ↗
- Ecolab Inc., Section 10b CEO total. DEF 14A, filed 2026-03-20. CEO total compensation as printed in Ecolab Inc.'s own proxy. As printed: 17,404,935. View filing ↗
- Bausch Health Companies Inc., Section 10b CEO total. DEF 14A, filed 2026-04-08. CEO total compensation as printed in Bausch Health Companies Inc.'s own proxy. As printed: 16,877,326. View filing ↗
- The Hershey Company, Section 10b CEO total. DEF 14A, filed 2026-03-25. CEO total compensation as printed in The Hershey Company's own proxy. As printed: 16,806,399. View filing ↗
- Colgate-Palmolive Company, Section 10b CEO total. DEF 14A, filed 2026-03-25. CEO total compensation as printed in Colgate-Palmolive Company's own proxy. As printed: 16,478,196. View filing ↗
- Kimberly-Clark Corporation, Section 10b CEO total. DEF 14A, filed 2026-03-23. CEO total compensation as printed in Kimberly-Clark Corporation's own proxy. As printed: 15,320,405. View filing ↗
- Viatris Inc., Section 10b CEO total. DEF 14A, filed 2026-04-02. CEO total compensation as printed in Viatris Inc.'s own proxy. As printed: 15,273,331. View filing ↗
- International Flavors & Fragrances Inc (subject), Section 10b CEO total. DEF 14A, filed 2026-03-18. CEO total compensation as printed in International Flavors & Fragrances Inc's own proxy. As printed: 15,002,866. View filing ↗
- Constellation Brands, Inc., Section 10b CEO total. DEF 14A, filed 2026-06-08. CEO total compensation as printed in Constellation Brands, Inc.'s own proxy. As printed: 14,209,126. View filing ↗
- General Mills, Inc., Section 10b CEO total. DEF 14A, filed 2026-08-13. CEO total compensation as printed in General Mills, Inc.'s own proxy. As printed: 14,018,052. View filing ↗
- The Clorox Company, Section 10b CEO total. DEF 14A, filed 2026-10-07. CEO total compensation as printed in The Clorox Company's own proxy. As printed: 14,000,460. View filing ↗
- Ball Corporation, Section 10b CEO total. DEF 14A, filed 2026-03-17. CEO total compensation as printed in Ball Corporation's own proxy. As printed: 13,486,942. View filing ↗
- Ingredion Incorporated, Section 10b CEO total. DEF 14A, filed 2026-04-08. CEO total compensation as printed in Ingredion Incorporated's own proxy. As printed: 12,932,234. View filing ↗
- McCormick & Company, Inc., Section 10b CEO total. DEF 14A, filed 2026-02-18. CEO total compensation as printed in McCormick & Company, Inc.'s own proxy. As printed: 10,831,581. View filing ↗
- Celanese Corporation, Section 10b CEO total. DEF 14A, filed 2026-03-04. CEO total compensation as printed in Celanese Corporation's own proxy. As printed: 10,137,072. View filing ↗
- Church & Dwight Co., Inc., Section 10b CEO total. DEF 14A, filed 2026-03-19. CEO total compensation as printed in Church & Dwight Co., Inc.'s own proxy. As printed: 9,799,678. View filing ↗
- Keurig Dr Pepper Inc., Section 10b CEO total. DEF 14A, filed 2026-04-24. CEO total compensation as printed in Keurig Dr Pepper Inc.'s own proxy. As printed: 8,217,032. View filing ↗
- Catalent, Inc., Section 10b CEO total. DEF 14A, filed 2023-12-15. CEO total compensation as printed in Catalent, Inc.'s own proxy. As printed: 6,583,672. View filing ↗
- Section 10a, Bausch Health Companies Inc. reciprocity. DEF 14A. Bausch Health Companies Inc.'s most recent proxy was read; its disclosed peer group does not include International Flavors & Fragrances Inc. View filing ↗
- Section 10a, Celanese Corporation reciprocity. DEF 14A. Celanese Corporation names International Flavors & Fragrances Inc in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, The Clorox Company reciprocity. DEF 14A. The Clorox Company's most recent proxy was read; its disclosed peer group does not include International Flavors & Fragrances Inc. View filing ↗
- Section 10a, Corteva, Inc. reciprocity. DEF 14A. Corteva, Inc. names International Flavors & Fragrances Inc in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Ecolab Inc. reciprocity. DEF 14A. Ecolab Inc.'s most recent proxy was read; its disclosed peer group does not include International Flavors & Fragrances Inc. View filing ↗
- Section 10a, General Mills, Inc. reciprocity. DEF 14A. General Mills, Inc.'s most recent proxy was read; its disclosed peer group does not include International Flavors & Fragrances Inc. View filing ↗
- Section 10a, McCormick & Company, Inc. reciprocity. DEF 14A. McCormick & Company, Inc. names International Flavors & Fragrances Inc in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Viatris Inc. reciprocity. DEF 14A. Viatris Inc.'s most recent proxy was read; its disclosed peer group does not include International Flavors & Fragrances Inc. View filing ↗
- Section 10a, Zoetis reciprocity. DEF 14A. Zoetis's most recent proxy was read; its disclosed peer group does not include International Flavors & Fragrances Inc. View filing ↗
- Section 10a, Constellation Brands, Inc. reciprocity. DEF 14A. Constellation Brands, Inc.'s most recent proxy was read; its disclosed peer group does not include International Flavors & Fragrances Inc. View filing ↗
- Section 10a, Ingredion Incorporated reciprocity. DEF 14A. Ingredion Incorporated names International Flavors & Fragrances Inc in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, The Estée Lauder Companies Inc. reciprocity. DEF 14A. The Estée Lauder Companies Inc. names International Flavors & Fragrances Inc in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Catalent, Inc. reciprocity. DEF 14A. Catalent, Inc.'s most recent proxy was read; its disclosed peer group does not include International Flavors & Fragrances Inc. View filing ↗
- Section 10a, Ball Corporation reciprocity. DEF 14A. Ball Corporation names International Flavors & Fragrances Inc in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, The Hershey Company reciprocity. DEF 14A. The Hershey Company's most recent proxy was read; its disclosed peer group does not include International Flavors & Fragrances Inc. View filing ↗
- Section 10a, Keurig Dr Pepper Inc. reciprocity. DEF 14A. Keurig Dr Pepper Inc.'s most recent proxy was read; its disclosed peer group does not include International Flavors & Fragrances Inc. View filing ↗